AVDL - Avadel Pharmaceuticals EPS beats by $0.09 March, 09 2021 07:05 AM Avadel Pharmaceuticals plc Avadel Pharmaceuticals (AVDL): Q4 GAAP EPS of -$0.19 beats by $0.09.Cash, cash equivalents and marketable securities of $221.4MPress Release For further details see: Avadel Pharmaceuticals EPS beats by $0.09